Announcements Trials
Browse Landscape

Phase

Phase NA 23Phase 4 18Phase 3 14Phase 2 7Phase 1/2 4Phase EARLY_PHASE1 2Phase 2/3 2Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2Cancer Pain 2Pain 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Morphine × Clear all
NCT02078089 2017-01-31

Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain

Indiana University

Phase 1 Terminated
1 enrolled

Cancer Pain, Neoplasms

NCT00125684 2012-01-19

Bioavailability and Effectiveness of Transdermally Administered Morphine

AHS Cancer Control Alberta

Phase 1 Completed
6 enrolled

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡